Immunotherapy-resistant neuropathic pain and fatigue predict quality-of-life in contactin-associated protein-like 2 antibody disease

Immunotherapy-resistant neuropathic pain and fatigue predict quality-of-life in contactin-associated protein-like 2 antibody disease

The long-term clinical outcomes and associated prognostic factors in contactin-associated protein-like 2 (CASPR2)-antibody diseases are unknown. A total of 75 participants with CASPR2 antibodies were longitudinally assessed for disability, quality-of-life, and chronic pain. Although most symptoms im...

Full description

Bibliographic Details
Main Authors: Ceronie, B, Strippel, C, Uy, C, Paneva, S, Makuch, M, Soleimani, B, Turaga, S, Binks, S, Ramanathan, S, Michael, S, Varley, J, Easton, A, Themistocleous, A, John Dawes, Bennett, DL, Irani, A, Handel, AE, Irani, SR
Format: Journal article
Language:English
Published: Wiley 2025

Similar Items